CDSCO
- Status: likely_approved
🇮🇳 Gilotrif in India
Gilotrif (afatinib) regulatory status in India.
Marketing authorisation
Gilotrif in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in India
Frequently asked questions
Is Gilotrif approved in India?
Yes. CDSCO has authorised it.
Who is the marketing authorisation holder for Gilotrif in India?
Boehringer Ingelheim is the originator. The local marketing authorisation holder may differ — check the official source linked above.